Register to use all the features of this website, including selecting clinical areas of interest and “favourite” articles, taking part in quizzes and much more.
Hint: If you are a General Practitioner your username may be your MCNZ#
About us | FAQ | Contact us | Terms of use
Interactive quizzes are based on material found in Best Practice Journal and Best Tests. Initially, quizzes are posted out with journals and GPs are invited to submit their answers for CME credits.
Register or Log in to take part in quizzes.
Login to my bpac.
Don't have an account? Register to use all the features of this website, including selecting clinical areas of interest, taking part in quizzes and much more.
Older people, particularly those who are frail and with multiple morbidities, are most susceptible to the cumulative effects... View Article
Patients taking oral anticoagulants require appropriate management in order to receive the maximum benefit from treatment with... View Article
Metoprolol succinate accounts for almost three-quarters of the beta-blockers dispensed in New Zealand. There is, however, little... View Article
Subsidy changes for medicines used to treat patients with COPD came into effect on March 1, 2016. In this article we discuss how... View Article
The risks and benefits of treatment with inhaled corticosteroids (ICS) are different for individual patients with COPD. There... View Article
Dabigatran (Pradaxa) is now available in New Zealand, fully funded, without Special Authority, as an alternative oral anticoagulant... View Article
Pharmacogenomics for General Practitioners: Time for clinical application View Article
Bioequivalence is established by undertaking a single or in certain circumstances a number of bioequivalence studies. Most bioequivalence... View Article
In New Zealand, Medsafe is responsible for the regulation of generic medicines. This involves evaluating the manufacturing processes,... View Article
Antiplatelet drugs including aspirin, clopidogrel and dipyrimadole, reduce the incidence of cardiovascular events by about 20-25%... View Article
From July 2007, Glaxo Smith Kline has distributed a new formulation of Eltroxin 50 microgram and 100 microgram. Since then, there... View Article
• Calcium Supplementation and the risk of myocardial infarction • Use of eGFR for drug dose adjustment• Compulsive gambling... View Article
An overview of the CYP450 system with particular reference to the metabolism of antidepressant drugs. View Article
Explains bioequivalence, how it’s regulated in New Zealand and the main validity issues. View Article
Can smoking cessation affect the dose of antipsychotics?Do statins cause nightmares?How important is it to give simvastatin at... View Article
In this article we provide an overview and guidance on the management of patients taking lithium. View Article
Pharmacogenetics: relevance in the treatment of depression View Article